New from our collaboration with Pathology @BrighamWomens@BrighamResearch - we assessed the performance of new generation #fentanyl assays to define their performance in clinical care:
https://t.co/xTQfjgFRaE
Coming back from another awesome #acmt2024 where we met our newest cohort of the ANTIDOTE program a r25 with @Dr_Carreiro and @NIDAnews. Awesome meeting Junior faculty toxicologists and hearing from POs at NIDA and NIAAA on k awards
Proud to join colleagues across the world to develop cannabis/cannabinoid guidelines for adults with cancer with @ASCO@DanaFarber@BrighamResearch: https://t.co/bUC8NhPWUW
One of the most important things we wanted to do here was break down the #stigma barriers that individuals will substance use won't engage in technologies to address comorbid disease. This analysis shows that sub use was not associated with MSM willingness to use #digitalpills
Excited to share our new manuscript on formative usability and acceptability of digital pill systems for #heartfailure#adherence measurement using #digitalpills in @jmirpub
https://t.co/rSLjjsoLe2
Excited to participate with our close colleagues @MIT on the new @ARPA_H initiative to advance our knowledge and treatment of metabolic disease! @BWHEmergencyMed
https://t.co/MZ8fuIf35c
Discussing work by @DrTiffanyGlynn on understanding strategies to reach individuals with hiv risk using technologies in the emergency dept @HICSSnews#hicss57
Work with our colleagues @FenwayHealth on perspectives of sexual networking of MSM identifying as persons of color during COVID-19
https://t.co/OeScv5EOH4
New work from our group led by @Dr_GoldiTox on updates in current management of beta blocker and calcium channel blocker toxicity in European Heart Journal @ESC_Journals: https://t.co/PX3mdgTCy6
Although fentanyl is now the dominant driver of the U.S. opioid epidemic, our health care system has struggled to adapt toxicology screening practices to this reality. Read the Perspective by Drs. @BrianBarnettMD, @PeterRchai & Joji Suzuki: https://t.co/RquL3rIsYt
our perspective on increasing access to #fentanyl testing and increasing access to point of care testing for those with #oud@NEJM https://t.co/jyww46bDA4